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Abstract
Background: Evidence suggests that tumor cells exposed to some DNA damaging agents are more likely to die if
they retain microscopically visible gH2AX foci that are known to mark sites of double-strand breaks. This appears to
be true even after exposure to the alkylating agent MNNG that does not cause direct double-strand breaks but
does produce gH2AX foci when damaged DNA undergoes replication.
Methods: To examine this predictive ability further, SiHa human cervical carcinoma cells were exposed to 8 DNA
damaging drugs (camptothecin, cisplatin, doxorubicin, etoposide, hydrogen peroxide, MNNG, temozolomide, and
tirapazamine) and the fraction of cells that retained gH2AX foci 24 hours after a 30 or 60 min treatment was
compared with the fraction of cells that lost clonogenicity. To determine if cells with residual repair foci are the
cells that die, SiHa cervical cancer cells were stably transfected with a RAD51-GFP construct and live cell analysis
was used to follow the fate of irradiated cells with RAD51-GFP foci.
Results: For all drugs regardless of their mechanism of interaction with DNA, close to a 1:1 correlation was
observed between clonogenic surviving fraction and the fraction of cells that retained gH2AX foci 24 hours after
treatment. Initial studies established that the fraction of cells that retained RAD51 foci after irradiation was similar
to the fraction of cells that retained gH2AX foci and subsequently lost clonogenicity. Tracking individual irradiated
live cells confirmed that SiHa cells with RAD51-GFP foci 24 hours after irradiation were more likely to die.
Conclusion: Retention of DNA damage-induced gH2AX foci appears to be indicative of lethal DNA damage so that
it may be possible to predict tumor cell killing by a wide variety of DNA damaging agents simply by scoring the
fraction of cells that retain gH2AX foci.
Background
Several DNA repair pathways have evolved to maintain
cell viability after exposure of mammalian cells to DNA
damaging agents. Sufficiently high doses of drugs or
radiation cause cell killing, and it seems reasonable to
expect that those cells that can repair DNA damage will
s u r v i v ew h i l et h o s eu n a b l et o repair their damage will
die. Sensitive detection of residual DNA damage at the
level of the individual cell could allow us to identify
treatment resistant subpopulations within tumors. This
possibility can now be examined by making use of the
fact that complex DNA lesions such as DNA double-
strand breaks (DSBs) are marked by microscopically
visible gH2AX foci [1].
DSBs rapidly activate kinases that phosphorylate his-
tone H2AX. Resulting gH2AX foci can be used to iden-
tify the number and location of DSBs and to follow
their fate during recovery [2,3]. The fraction of tumor
cells that retain gH2AX foci 24 hours after irradiation
has been correlated with the fraction of cells that fail to
divide and form colonies [4,5]. Similar results have been
reported for RAD51 recombinase, a key player in DSB
repair by homologous recombination [6]. RAD51 mole-
cules also accumulate slowly as microscopically visible
foci that are often co-expressed in cells with gH2AX
foci [7,8]. Recently, RAD51 foci have been found in
association with persistent DSBs [9]. What is not known
for certain is whether the cells that retain gH2AX or
RAD51 foci 24 hours after irradiation are actually the
cells that die.
gH2AX foci begin to form immediately after irradia-
tion, reaching a maximum size about 30 or 60 min later
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residual foci may remain in some cells for days after
exposure and may mark unrepaired or misrepaired sites
[10,11]. Importantly, residual foci appear to be replicated
and retained by daughter cells [4,5]. Since rapid loss of
gH2AX is contingent upon functional DNA repair, it is
not surprising that retention of gH2AX foci has been
associated with loss of clonogenic potential. Several stu-
dies have reported that repair-deficient cell lines retain
more foci and more cells with foci when analyzed 24
hours after irradiation [12,13]. The percentage of cells
that retained gH2AX foci 24 hours after irradiation was
correlated with the percentage of cells that lost clono-
genicity, thus making it possible to use the fraction of
cells with residual foci as a way to estimate sensitivity to
killing by ionizing radiation [4,5].
DSBs may be produced either directly or indirectly [2].
Direct DSBs occur as a result of exposure to ionizing
radiation as well as selected drugs including bleomycin
and the topoisomerase II inhibitor, etoposide. Indirectly
produced DSBs can arise when a single-strand break,
crosslinked DNA, or damaged DNA base meets a repli-
cation fork [14]. Phosphorylation of H2AX may also
occur indirectly during repair of base damage [15].
Arguably also an indirect mechanism, extensive H2AX
phosphorylation occurs as a result of DNA fragmenta-
tion during the process of apoptosis [16]. Therefore
directly or indirectly, the majority of DNA damaging
agents are likely to cause H2AX phosphorylation, and
cells that subsequently retain gH2AX foci may be more
likely to die no matter how the DNA damage was initi-
ally produced. To explore this possibility, the fraction of
cells that retained gH2AX foci was compared to the
fraction of clonogenic surviving cells measured after a
short exposure to 8 drugs known to damage DNA and
cause H2AX phosphorylation [2].
A correlation between clonogenicity and fraction of
cells lacking foci does not constitute proof that cells
that retain gH2AX foci are the cells that will die. Real-
time imaging of gH2AX foci is complicated by the
necessity of identifying the phosphorylated form of
H2AX. However, RAD51 molecules also aggregate as
clusters at sites of DNA damage in irradiated cells and
are retained by gH2AX [10]. When labeled with green
fluorescent protein (GFP), RAD51-GFP can be used for
live cell analysis to determine the fate of an individual
cell that retains RAD51 foci [17,18]. The ability to fol-
low live cells allowed a direct test of the hypothesis that
cells that retain RAD51 foci 24 hours after irradiation
are the cells that will eventually die.
Methods
Cell lines and drug treatment
Chinese hamster V79 and CHO cells were maintained
by twice weekly sub-cultivation in minimal essential
medium (MEM) containing 10% fetal bovine serum
(FBS). SiHa human cervical carcinoma cells and HT144
human melanoma cells were obtained from American
Type Culture Collection. SKOV3 human ovarian carci-
noma cells were obtained from the DCTD tumor reposi-
tory in Frederick MD. M059J and M059K human glioma
cell lines were obtained from Dr. J. Allalunis-Turner,
Cross Cancer Center. All tumor cell lines were sub-cul-
tured twice weekly in MEM containing 10% FBS.
To obtain cells that expressed RAD51-GFP, SiHa cells
were transfected with a plasmid kindly supplied by Dr.
Roland Kanaar [18]. Transfection was accomplished
using Lipofectamine Plus using the protocol supplied by
Invitrogen; stably transfected cells were selected by
growth in 200 μg/ml G418 (Gibco), and a clone was
chosen for further studies.
For drug treatment, 5 × 10
5 cells/60 mm dish and
were exposed as exponentially growing monolayers to
selected drugs usually for 30 min or for 60 min (cispla-
tin, temozolomide) in medium containing 5% FBS. Tira-
pazamine treatment was conducted using cells in
suspension culture incubated for 30 min in drug-con-
taining medium pre-equilibrated for one hour with 95%
oxygen and 5% CO2. Cisplatin was obtained from
Mayne Pharma and diluted from a stock solution of 1
mg/ml. Temozolomide was prepared in DMSO using a
250 mg capsule from Schering Canada. Etoposide was
purchased from Novopharm and diluted from a stock
concentration of 20 mg/ml. Doxorubicin, MNNG and
hydrogen peroxide (H2O2) were obtained from Sigma
and diluted in medium. Camptothecin was purchased
from GBiosciences and prepared from a stock solution
of 2 mM in DMSO. Tirapazamine was supplied by Dr. J.
Martin Brown, and diluted from a stock solution of 2.5
mM in phosphate buffered saline. For experiments using
X-rays, cells were exposed using a 300 kV unit at a dose
rate of 5.2 Gy/min.
After drug incubation, drug was removed, dishes were
rinsed several times, and cells were incubated for 24
hours in fresh complete medium. Trypsin treatment
(0.1% for 5 min) was used to produce a single cell sus-
pension. Samples of single cells were plated in duplicate
to measure colony formation and resulting colonies
were stained and counted two weeks later. The survival
of the treated cells was normalized to the plating effi-
ciency of the non-treated cells. Experiments were per-
formed 2-4 times using a range of drug doses. The
remaining cells were fixed in 70% ethanol for analysis by
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antibody binding.
Flow Cytometry for gH2AX
Antibody staining was performed as previously
described using mouse monoclonal anti-phosphoserine-
139 H2AX antibody (Abcam #18311; 1:4000 dilution)
[19]. After secondary antibody labelling with Alexa-488
conjugated goat anti-mouse IgG, cells were rinsed and
resuspended in 1 μg/mL 4’,6-diamidino-2-phenylindole
dihydrochloride hydrate (DAPI; Sigma), a UV-excitable
DNA stain. Samples were analyzed using a dual-laser
Coulter Elite flow cytometer using UV and 488 nm laser
excitation. The gH2AX signal was divided by DNA con-
tent per cell to account for differences in cell cycle dis-
tribution, and results were normalized relative to
untreated controls within each experiment. Normalized
gH2AX intensity is reported for all of the cells within
the population.
Live cell analysis of RAD51-GFP
On average, one SiHa-RAD51-GFP cell was seeded into
each well of an 8 well chamber slide with coverslip bot-
toms (Nalge Nunc International) containing 100 μl fresh
complete medium and 100 μl conditioned medium pre-
pared by filtering the complete medium recovered after
two days of growth with high density cell cultures. Cells
were allowed 4 hours to attach before exposing the
chamber slide to 0 or 3 Gy and returning the chambers
to the incubator for 24 hours. After 24 hours, each well
was examined using a Zeiss inverted microscope with a
63× objective. To ensure high plating efficiency, analysis
was restricted to cell doublets since this indicated that
cells had attached and divided in the 24 hours period
after irradiation. Images of cell doublets were obtained
under phase and 488 nm excitation, and the location of
the doublet in the well was noted. Almost invariably,
both cells of a doublet exhibited RAD51-GFP foci or
foci were absent from both cells at 24 hours. After scor-
ing for the presence of foci, chamber slides were
returned to the incubator for 2 weeks to allow time for
colonies with greater than 50 cells to form. Approxi-
mately 40 doublets with foci and 40 doublets without
foci were scored for clonogenicity.
Immunohistochemistry for RAD51 and gH2AX
Antibody stained cells prepared for flow cytometry as
described above were cytospun onto microscope slides.
Alternatively, cells grown on coverslips were fixed for 20
min in 2% freshly prepared paraformaldehyde before
incubating with mouse monoclonal antibodies against
gH2AX (Upstate, 1:500 dilution) and/or rabbit polyclo-
nal antibodies against RAD51 (Calbiochem, 1:500 dilu-
tion or Oncogen Sciences, 1:100 dilution). Cells were
viewed using a Zeiss epifluorescence microscope using a
100× Neofluor objective and images were analyzed for
foci/nucleus. Analysis of foci/nucleus was always
concluded before analysis of clonogenicity so that objec-
tivity of scoring using image analysis was maintained.
Experiments were repeated 3 times and independent
results for each sample (clonogenic fraction and # cells
lacking foci) were plotted.
Comet assays
Alkaline and neutral versions of the comet assay were
used to measure MNNG-induced DNA single-strand
breaks and DSBs respectively. Exponentially growing
V79 hamster cells were exposed to MNNG for 30 min
and then embedded in low gelling temperature agarose
on a microscope slide. For the alkaline comet assay,
slides were placed in a high-salt lysis solution for 1 h at
pH 12.3 as previously described [20]. The neutral comet
assay was performed using a 4 h lysis at 50°C, pH 8.3,
as previously described [21]. For each drug dose and
time, 150 comet images were analysed for DNA content,
tail moment and percentage of DNA in the comet tail.
Mean values are shown.
Results
Comparison between gH2AX formation, DNA break
induction and cell killing by MNNG
Flow cytometry analysis of H2AX phosphorylation is a
practical method to assess the kinetics of phorphoryla-
tion of this DNA damage reporter as well as the impor-
tance of cell cycle position. Flow cytometry profiles of
gH2AX expression versus DNA content indicated that
V79 cells respond differently to low and high doses of
MNNG when examined 1 h after a 30 min exposure to
the drug. Initial accumulation of gH2AX was limited to
cells with S phase DNA content after treatment with
low drug doses, consistent with replication fork collapse
as a cause of H2AX phosphorylation (Fig. 1a-c). How-
ever, after exposure to higher drug doses, gH2AX devel-
oped in cells in all phases of the cell cycle (Fig. 1d-f).
Since our goal was to determine whether retention of
gH2AX might be useful as an indicator of cell viability
after exposure to genotoxic drugs, the loss of clonogenic
ability was measured following a 30 min exposure to
MNNG. Exponential cell killing was observed for V79
cells treated for 30 min with 0 to 5 μg/ml MNNG (Fig.
2a). A dose dependent increase in the population aver-
age expression of gH2AX was also detected using flow
cytometry, and phosphorylation of H2AX continued to
rise for several hours after exp o s u r e( F i g .2 b ,c ) .T h i si s
consistent with gH2AX formation occurring as damaged
DNA undergoes replication. By 24 hours after a 30 min
drug treatment, the expression of gH2AX remained high
(Fig. 2c) suggesting that many sites marked by gH2AX
foci remained unrepaired. Nonetheless, when analyzed
using flow cytometry, 7-22% of the cells within these
populations expressed control levels of gH2AX (data not
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these populations.
MNNG is an alkylating agent known to produce both
DNA single-strand breaks as well as damage to the
DNA bases. Production of alkali-labile DNA lesions
including single-strand breaks and base damage was
measured using the alkaline comet assay, a gel electro-
phoresis method that measures migration of broken
DNA strands from individual nuclei. Tail moment, a
measure of the amount and distance of DNA migration,
was dose dependent, and there was no indication that
the number of alkali-labile sites increased with time
after exposure (Fig. 2d). Since gH2AX is formed in
response to direct or indirectly-produced double-strand
breaks and not single-strand breaks, the presence of
double-strand breaks was also measured using a neutral
version of the comet assay. Results indicated a small
increase tail moment as a function of time after treat-
ment with much higher doses (Fig. 2e), consistent with
the observed increase in gH2AX (Fig. 2b). A comparison
of the slopes in Fig. 2d and 2e indicated that approxi-
mately 40 times more alkali-labile lesions were produced
than DNA double-strand breaks. Rejoining of alkali-
labile lesions was negligible over the first few hours;
h o w e v e r ,h a l fo ft h eb r e a k sw e r er e j o i n e db y2 4h o u r s
after treatment (Fig. 2f). The lack of a decrease in aver-
age gH2AX measured for all cells within the population
after 24 hours could suggests that much of this repair,
even after exposure to low doses, may not have been
accurate or that a subset of lesions (e.g., single-strand
breaks) that were repaired did not give rise to gH2AX
foci. As residual gH2AX is a measure of the loss of foci
as well as possible formation of new foci, the lack of a
decrease in gH2AX does not necessarily indicate lack of
repair of DNA breaks. Nonetheless, no rejoining of
DNA double-strand breaks was detected after exposure
to 50 μg/ml MNNG (data not shown). These results
confirm that MNNG induces double-strand breaks that
can be detected using the neutral comet assay but only
after exposure to supra-lethal doses. The neutral comet
assay lacks the sensitivity to predict response to MNNG
in the low dose region.
The relation between clonogenic surviving fraction
(Fig 3a) and fraction of cells with residual gH2AX foci
(Fig. 3b) was then compared using SiHa human cervical
carcinoma cells exposed for 30 min to MNNG. To
improve resolution for detecting the relevant resistant
cells within the population, the fraction of nuclei lacking
foci was scored microscopically 24 hours after exposure
to MNNG. The fraction of cells lacking foci at 24 hours
was then compared with the fraction of cells from the
same treated population that retained clonogenicity as
measured two weeks later. A good correlation was
observed between clonogenicity and fraction of cells
l a c k i n gf o c i2 4h o u r sa f t e rt r e a t m e n t( F i g .3 c )a n dt h e r e
was a progressive increase in the number of foci per cell
Figure 1 Development of gH2AX after MNNG treatment. Flow cytometric analysis was used to detect gH2AX formation in V79 cells exposed
to MNNG for 30 min and then allowed 1 h to develop gH2AX foci. Single cells were fixed and analyzed for gH2AX antibody binding in relation
to DNA content using flow cytometry. Cells that expressed control levels of gH2AX are contained within the boxes and are given as percentages.
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MNNG-treated cells show the heterogeneity in foci
number per nucleus (Fig. 3g-i). Therefore unlike the
neutral comet assay, retention of gH2AX foci appears to
have the requisite sensitivity to predict cell survival over
the first log or two of cell killing.
Ability of residual gH2AX to predict clonogenic survival
after exposure to other drugs
To determine whether the fraction of cells with residual
gH2AX foci would predict surviving fraction for other
drugs, the response of SiHa cells to a broader range of
drugs was subsequently examined. Drug concentrations
that typically produced no more than 1 log of cell kill
were used to avoid rapid cell loss often associated with
higher drug doses [22]. In all cases, SiHa cells were
exposed for 30 or 60 min to each drug and incubated
for 24 hours after drug treatment to allow time for
DNA repair and concomitant loss of gH2AX foci. After
24 hours, cells were plated for measurement of
clonogenic fraction or fixed for measurement of the
fraction of cells lacking residual gH2AX foci. Clonogenic
fraction and the relative fraction of cells lacking foci 24
h after exposure showed similar dose response patterns
for each drug (Fig. 4). The slopes comparing clonogeni-
city with residual foci together with correlation coeffi-
cients are provided in Table 1. The 95% confidence
limits on the slopes included the value of one for 7/8
drugs, indicating that the fraction of cells that retained
residual gH2AX foci was directly comparable to the
fraction of cells that would die. The lowest surviving
fraction produced by temozolomide was only 0.58 which
may have been insufficient to accurately estimate the
slope. These results indicate that residual gH2AX is use-
ful for predicting clonogenic fraction following exposure
to a broad range of genotoxic drugs. This suggests, but
does not prove, that cells that retain gH2AX foci 24
hours after drug treatment are likely to die.
Figure 2 T o x i c i t y ,D N Ad a m a g e ,a n dgH2AX formation in V79 cells exposed to MNNG. Panel a: Clonogenic survival after a 30 min
exposure of V79 cells to MNNG. Panel b: Expression of gH2AX in V79 cells relative to untreated cells as a function of dose of MNNG. Panel c:
Time-dependence of gH2AX formation in V79 cells after exposure to low doses of MNNG. Panel d: Alkali-labile lesions measured using the
alkaline comet assay showing drug dose dependence for different times of recovery after a 30 min exposure. Panel e: DNA double-strand breaks
measured using the neutral comet assay as a function of drug dose and time after a 30 min exposure. Panel f: Rejoining of alkali-labile lesions as
a function of time after exposure of V79 cells to MNNG.
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As it was not possible to confirm directly that cells that
retained gH2AX foci 24 hours after treatment were the
cells that died, we attempted to accomplish this in
another way by using live-cell analysis of SiHa cells
expressing RAD51-GFP. First, it was important to con-
firm results of a previous study that showed that the
fraction of cells that died after irradiation was correlated
with the fraction of cells with RAD51 foci 24 hours after
irradiation [6]. Exponentially growing SiHa cells were
exposed to ionizing radiation and allowed to recover for
24 hours before plating for survival or fixing in 2% par-
aformaldehyde for analysis of RAD51 and gH2AX foci.
The fraction of SiHa cells that expressed gH2AX and
RAD51 foci 24 hours after irradiation increased with
dose, and the majority of foci-positive cells exhibited
Figure 3 Toxicity in relation to residual gH2AX in SiHa cells exposed to MNNG. Panel a: Clonogenic surviving fraction after a 30 min
exposure of SiHa cells to MNNG followed by a 24 hours recovery period. Panel b: Fraction of cells without gH2AX foci 24 hours after exposure
to MNNG. Results are expressed relative to the endogenous expression of gH2AX; typically 60-70% of SiHa cells lack foci. Panel c: Comparison
between fraction of cells lacking residual gH2AX foci and clonogenic fraction. Panels d-f: Distribution of gH2AX foci per cell. Panels g-i:
Representative antibody-stained images of cells exposed 0, 0.5 and 1 μg/ml MNNG showing foci numbers and distribution.
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About 5-10% of the cells that lacked RAD51 foci exhib-
ited gH2AX foci, but <5% of cells showed RAD51 foci
in the absence of gH2AX foci. As mitotic cells did not
exhibit RAD51 foci, this could account in part for the
presence of residual gH2AX foci in the absence of
RAD51 foci. Differences in rate of foci development and
removal may also account for minor discrepancies. The
correlation between the fraction of SiHa cells that
lacked RAD51 foci and surviving fraction after irradia-
tion was excellent (Fig. 5b). To determine whether this
correlation would hold for other cell types, several cell
lines were exposed to 2 Gy and examined for the pre-
sence of RAD51 foci 24 hours after irradiation. In agree-
ment with results of Sak et al. [6], the fraction of cells
that exhibited RAD51 foci 24 hours after exposure to 2
Gy was higher for the more radiosensitive cell lines (Fig.
5c). RAD51 foci appeared in many micronuclei 24 hours
after exposure, either alone or with gH2AX foci, and
daughter cell pairs showed similar RAD51 foci patterns
as has been reported for gH2AX foci (Fig 5d, e).
Although RAD51 foci may only mark a subset of the
double-strand breaks, the number of residual RAD51
foci per cell was not invariably lower than the number
of residual gH 2 A Xf o c i( F i g .5 e ) .T h e r e f o r e ,r e s i d u a l
RAD51 foci appear to behave much like residual gH2AX
foci, at least at 24 hours post-treatment, and should
therefore be useful for predicting response to treatment.
Use of RAD51-GFP transfected cells to determine cell
fateafter irradiation
Having established that the fraction of cells that retain
RAD51 foci is similar to the fraction of cells that die
after irradiation, SiHa cells were stably transfected with
a plasmid containing a RAD51-GFP reporter construct.
A clone with moderate RAD51-GFP expression (GFP
expression was 3.9 times background) that showed simi-
lar growth kinetics and radiation response as the paren-
tal cell line was selected (data not shown). Detection of
individual GFP-labelled foci was possible using live cells
(Fig. 6a), and excellent co-localization was seen between
RAD51-GFP and RAD51 antibody staining (Fig 6b).
Although RAD51-GFP filament formation was occasion-
ally observed, the majority of cells with RAD51-GFP
foci showed a punctuate pattern, and cells with RAD51-
GFP foci typically expressed gH2AX foci (Fig. 6c). The
number of cells with RAD51-GFP foci reached a maxi-
mum 16 - 24 h after irradiation (Fig. 6d), exhibiting
kinetics similar to those reported using immunoblotting
[23] but slower than observed using immunofluores-
cence staining (dotted line in Fig. 6d). This difference is
likely to be a resolution issue since sufficient RAD51-
GFP molecules must aggregate to become microscopi-
cally visible. The fraction of cells with microscopically
visible RAD51-GFP foci was similar to the fraction of
cells with antibody-labeled RAD51 foci 24 hours after 4
or 8 Gy (Fig. 6d). In SiHa cells exposed to 4 or 8 Gy,
the fraction of cells with RAD51-GFP foci was also simi-
lar to the fraction of cells with gH2AX foci when
detected microscopically (Fig. 6e). In SiHa cells sorted
Table 1 Correlation between residual gH2AX and cell killing in SiHa monolayers exposed to DNA damaging agents
DNA damaging agent Mechanism of interaction with
DNA
Likely mechanism(s) of gH2AX
formation
aSlope (95% confidence limits)
and correlation coefficient (r
2)
X-rays SSB, DSB, base damage Direct DSBs 0.95 (0.57-1.33)
r
2 = 0.95
Etoposide Topo II inhibitor Direct DSBs 1.17 (0.91-1.44)
r
2 = 0.91
Temozolamide Base alkylation Base damage leading to DSBs
during replication
b
0.62 (0.42-0.82)
r
2 = 0.82
MNNG Base alkylation Base damage leading to DSBs
during replication
b
0.79 (0.52-1.07)
r
2 = 0.87
Cisplatin Inter- and intra-strand crosslinks Inter- and intra-strand crosslinks
leading to DSBs during replication
b
0.77 (0.53-1.02)
r
2 = 0.87
Doxorubicin SSB, DSB, base damage, topo II
inhibitor
Direct DSBs and replication fork
blockage leading to DSBs
0.95 (0.88-1.03)
r
2 = 0.99
Tirapazamine SSB, DSB, base damage, topo II
inhibitor
Direct DSBs and replication fork
blockage leading to DSBs
1.06 (0.80-1.3)
r
2 = 0.90
Camptothecin Topo I inhibitor Replication fork blockage leading to
DSBs
0.83 (0.61-1.04)
r
2 = 0.85
Hydrogen peroxide SSB Opposed single-strand breaks 1.06 (0.85-1.26)
r
2 = 0.93
a The slope was obtained by plotting clonogenic surviving fraction versus the fraction of cells lacking foci.
b After exposure to very high drug doses, gH2AX forms independently of cell cycle phase and may implicate opposed repair sites as responsible for triggering
H2AX phosphorylation.
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then stained and reanalyzed for gH2AX using flow cyto-
metry, there was a good correlation between the expres-
sion of these two molecules (Fig. 6f). Therefore RAD51-
GFP expression appears to be a useful surrogate for
gH2AX expression when analyzed 24 hours after
treatment.
To determine whether SiHa cells that exhibit RAD51-
GFP foci 24 hours after irradiation are more likely to
die, SiHa-RAD51-GFP cells were exposed to 0 or 3 Gy.
Twenty-four hours later, daughter-cell doublets were
scored for the presence or absence of GFP foci. Preli-
minary results established that 58% of unirradiated cells
formed doublets by 24 hours and a similar percentage
(50%) of those exposed to 3 Gy formed doublets. For
control cells, 95% of the doublets lacked foci at 24
hours and for the irradiated cells, 60% lacked foci. After
allowing 2 weeks for doublets to form colonies, wells
were scored. Only 16% of the doublets with RAD51-
GFP foci after 24 h formed colonies whether they were
exposed to 0 or 3 Gy (Fig. 6g) whereas 75-82% of doub-
lets without foci were able to form colonies. These
results support the hypothesis that cells that retain foci
24 hours after irradiation are the cells that lose clono-
genic potential.
Discussion
We have previously reported that the fraction of SiHa
cells that exhibit more than the background level of
gH2AX 24 hours after treatment can be correlated with
the fraction of cells that will ultimately die after expo-
sure to X-rays and/or cisplatin [5,24]. We now show
Figure 4 Comparison between clonogenic fraction and fraction of cells lacking residual gH2AX foci for SiHa cells exposed to 8 drugs.
With the exception of tirapazamine treatment that was conducted in suspension culture under anoxia, attached cells were exposed at 37°C in
complete medium for either 30 min or 60 min (cisplatin, temozolomide). After rinsing, cells were allowed to recover for 24 hours before
microscopic analysis of gH2AX foci and plating to measure clonogenic fraction. Combined results from 2-4 experiments are shown.
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after exposure to a variety of DNA damaging drugs, sev-
eral of which do not produce direct DSBs. DSBs can be
formed indirectly by two closely opposing single-strand
breaks. This is likely to be the case with hydrogen per-
oxide since sufficiently high drug doses will produce
DSBs [25]. MNNG-induced double-strand breaks were
also detected using the neutral comet assay after expo-
sure to high doses (Fig. 2e), and closely opposed
damaged sites, perhaps undergoing base excision repair
could be responsible [26]. However, as a high lysis tem-
perature was used for the neutral comet experiments,
opposing heat-labile base damage sites may also be
involved in the formation of physical breaks detected
using this method [27].
Several patterns of gH2AX formation and loss have
been observed using the drugs listed in Table 1. Foci
reach a maximum size within an hour after exposure to
X-rays, tirapazamine, doxorubicin or etoposide. How-
ever, development of gH2AX is slower when DSB for-
mation requires transit through S phase, for example,
after treatment with cisplatin or low doses of MNNG.
Significant DSB rejoining was not detected during the
24 hours after treatment with MNNG and gH2AX levels
also remained high (Fig. 2c). The inability to repair
DSBs caused by MNNG was also suggested by Stojic
Figure 5 The fraction of cells with residual RAD51 foci is correlated with the fraction of cells that die. Panel a: SiHa cells were exposed
to X-rays and allowed to recover for 24 hours. Cells were fixed and co-immunostained for gH2AX and RAD51, and cells with foci were scored.
Results are the means and SD for 3 experiments. Panel b: The fraction of SiHa cells lacking RAD51 foci is compared with the clonogenic fraction
measured 24 hours after exposure to X-rays. Panel c: Several cell lines were exposed to 2 Gy, allowed to recover for 24 hours, and then
examined for the fraction of cells that lacked RAD51 foci. Panel d: RAD51 (green) and gH2AX (red) antibody staining of SiHa cells 24 hours after
exposure to 2 Gy. Nuclei are stained blue with DAPI. Panel e: 24 hours after exposure to 8 Gy. Note the micronuclei stained with antibodies to
RAD51 and/or gH2AX foci and the co-localization of some foci in some cells but not all cells.
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Page 9 of 12et al, [28] based on the persistence of gH2AX foci in
MNNG treated cells. Unfortunately, the presence of an
unrejoined double-strand br e a ka tt h es i t eo far e s i d u a l
gH2AX focus cannot be confirmed using a physical
method to detect DSBs since these methods lack suffi-
cient sensitivity. A subsequent paper by Stojic et al. indi-
cated that a different mechanism operated to induce
gH2AX foci after exposure to high MNNG doses (30
μM) because foci formation became independent of mis-
match repair which was associated with replication [29].
Our flow cytometry results (Fig. 1) support this observa-
tion by indicating that cell cycle position is important
for gH2AX focus formation after exposure to low but
not high (> 20 μg/ml) MNNG doses.
Although our results suggest that residual, not initial
gH2AX is the critical factor determining cell fate, initial
gH2AX can also be predictive for response if some cells
within a population are resistant to the induction of
DBSs. Etoposide causes DSBs only in the outer prolifer-
ating cells of multicellular spheroids; the non-proliferat-
ing inner fraction of cells do not develop gH2AX and
therefore survive treatment [30]. In this case, determin-
ing the fraction of cells lacking gH2AX immediately
after exposure was also predictive of cell survival [31].
In the same way, doxorubicin penetrates poorly through
the outer cells of spheroids so that only the outer cells
developed significant numbers of gH2AX foci. Again the
fraction of cells lacking foci immediately after exposure
was correlated with the fraction of cells that survived
Figure 6 RAD51-GFP as a live cell marker. Panel a: RAD51-GFP foci in live SiHa cells stably transfected with RAD51-GFP are shown 24 hours
after exposure to 8 Gy. The phase contrast image is indicated by red outlines. Panel b: Co-localization between RAD51-GFP and anti-RAD51
antibody staining (red) in an untreated SiHa cell. Panel c: Co-localization between RAD51-GFP (green) and gH2AX antibody staining (red) in SiHa
cells 24 hours after exposure to 8 Gy. Panel d: Analysis of the fraction of SiHa-RAD51-GFP cells that develop foci as a function of time after
exposure to 4 Gy or 8 Gy. Results from several experiments are pooled. The dotted line and open circles show the development of RAD51
antibody-labelled foci after exposure to 4 Gy. The single open triangle shows the fraction of RAD51 antibody-labeled cells 24 hours after 8 Gy.
Panel e: The fraction of cells that exhibit RAD51-GFP foci or gH2AX foci 24 hours after exposure to radiation, measured microscopically. Panel f:
SiHa-RAD51-GFP cells expressing high levels of RAD51-GFP after 24 hours after irradiation were sorted on the basis of GFP, fixed and stained for
gH2AX. The average intensity of the populations was measured using flow cytometry. The mean and standard error for 3 sorted populations is
shown. Panel g: Clonogenicity of SiHa-RAD51-GFP cells after 0 or 3 Gy exposure. Cells in 8-well dishes were irradiated and 24 hours later, wells
containing one or two doublets were scored for the presence or absence of gH2AX foci (daughter cell pairs show the same foci patterns).
Dishes were returned to the incubator for 2 weeks to form colonies. The fraction of doublets with foci that survived treatment or the fraction
lacking foci that survived treatment was calculated.
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Page 10 of 12[31]. However, by counting the fraction of cells lacking
foci 24 hours after treatment, the importance of repair
capacity as well as susceptibility to a direct-acting geno-
toxin can be included in the estimate of survival. More-
over, effects of drugs that produce gH2AX only when
cells transit S phase can also be evaluated, provided of
course that drug-treated cells are given an opportunity
to progress through the cell cycle.
A RAD51-GFP construct provided a way to directly
address the importance of residual DNA repair foci in
determining cell fate. Cells deficient in H2AX also show
a deficiency in homologous recombination and RAD51
focus formation [32,33], and it is possible that retention
of gH2AX may be the signal for retention of repair
molecules like RAD51 [10]. Most but not all cells with
RAD51-GFP foci 24 hours after irradiation failed to
form colonies. Similarly, most but not all cells lacking
foci did form colonies (Fig. 6g). Unfortunately, resolu-
tion for detecting foci was reduced under the technical
constraints imposed by live cell imaging in multiwells,
and 24 hours may not have been an optimum time to
score microscopically visible RAD51-GFP foci for all
cells. Although the answer was not unequivocal, it does
support the idea that residual DNA repair foci mark
cells that are likely to die. Since all of the DNA dama-
ging agents we have examined produced residual
gH2AX that were predictive of clonogenic survival, it
should be possible to use residual foci as a biomarker of
response to genotoxic agents.
There are limitations to the application of this
approach in vivo. Tumor heterogeneity is a major con-
sideration especially since both induction of DNA
damage and its repair are influenced by the tumor
microenvironment. Obtaining a representative biopsy
and/or multiple biopsies will be essential [34]. Second, it
is important to consider the endogenous expression of
gH2AX since this can be quite variable and will affect
the ability to detect residual gH2AX foci [35]. A pre-
treatment biopsy must also be obtained and if endogen-
ous gH2AX is excessive, prediction based on residual
foci may not be possible. Third, loss of heavily damaged
cells by apoptosis or other mechanisms within the first
24 hours after treatment, or sequestration of foci into
micronuclei before scoring will reduce the accuracy of
prediction. Although early apoptotic cells exhibit
gH2AX foci, necrosis secondary to apoptosis can result
in loss of the signal [16,36]. Finally, for drugs that pro-
duce foci only when DNA replicates, it will be necessary
to ensure that all treated cells have the opportunity to
transit S phase. In spite of these limitations, the recent
application of gH2AX to predict response to cisplatin
combined with radiation in xenograft tumors [24] indi-
cates that this approach has promise for early prediction
of tumor response to treatment. Moreover, it should be
possible to predict response not only to single drugs but
to combinations of DNA damaging agents.
Conclusions
Our results support the hypothesis that tumor cells that
retain gH2AX foci 24 hours after exposure to a DNA
damaging agent are unlikely to survive treatment. The
direct relationship between loss of clonogenic ability
and retention of gH2AX foci holds for drugs that
damage DNA by different mechanisms. Therefore, it
should be possible to identify drug-resistant tumor cells
simply by measuring the fraction of cells that lack resi-
dual gH2AX foci.
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